
BREAKING! First-of-its-kind study: 197 cancer patients treated with compounded Ivermectin (25mg) + Mebendazole (250mg). At 6 months: • 84.4% saw clinical benefit • 48.4% had tumor shrinkage or no evidence of disease • 86.9% completed treatment, mild side effects See ⬇️